BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32485312)

  • 1. Genomic profiling of sporadic liver metastatic colorectal cancer.
    González-González M; Gutiérrez ML; Sayagués JM; Muñoz-Bellvís L; Orfao A
    Semin Cancer Biol; 2021 Jun; 71():98-108. PubMed ID: 32485312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic characterization of liver metastases from colorectal cancer patients.
    Sayagués JM; Corchete LA; Gutiérrez ML; Sarasquete ME; Del Mar Abad M; Bengoechea O; Fermiñán E; Anduaga MF; Del Carmen S; Iglesias M; Esteban C; Angoso M; Alcazar JA; García J; Orfao A; Muñoz-Bellvis L
    Oncotarget; 2016 Nov; 7(45):72908-72922. PubMed ID: 27662660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays.
    Muñoz-Bellvis L; Fontanillo C; González-González M; Garcia E; Iglesias M; Esteban C; Gutierrez ML; Abad MM; Bengoechea O; De Las Rivas J; Orfao A; Sayagués JM
    Mod Pathol; 2012 Apr; 25(4):590-601. PubMed ID: 22222638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Impact of del(17p) and del(22q) as assessed by interphase FISH in sporadic colorectal carcinomas.
    González-González M; Muñoz-Bellvis L; Mackintosh C; Fontanillo C; Gutiérrez ML; Abad MM; Bengoechea O; Teodosio C; Fonseca E; Fuentes M; De Las Rivas J; Orfao A; Sayagués JM
    PLoS One; 2012; 7(8):e42683. PubMed ID: 22912721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer.
    González-González M; Fontanillo C; Abad MM; Gutiérrez ML; Mota I; Bengoechea O; Santos-Briz Á; Blanco O; Fonseca E; Ciudad J; Fuentes M; De Las Rivas J; Alcazar JA; García J; Muñoz-Bellvis L; Orfao A; Sayagués JM
    Cancer; 2014 Jul; 120(13):1948-59. PubMed ID: 24668684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis.
    Liu J; Cho YB; Hong HK; Wu S; Ebert PJ; Bray SM; Wong SS; Ting JC; Calley JN; Whittington CF; Bhagwat SV; Reinhard C; Wild R; Nam DH; Aggarwal A; Lee WY; Peng SB
    Sci Rep; 2020 Jul; 10(1):10725. PubMed ID: 32612211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
    Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
    Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the tumor suppressor SARDH in sporadic colorectal cancer: A functional and transcriptome profiling-based study.
    He H; Chen E; Lei L; Yan B; Zhao X; Zhu Z; Li Q; Zhang P; Zhang W; Xing J; Du L; Dong J; Yang J
    Mol Carcinog; 2019 Jun; 58(6):957-966. PubMed ID: 30693981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of novel low passage primary and metastatic colorectal cancer cell lines.
    Boot A; van Eendenburg J; Crobach S; Ruano D; Speetjens F; Calame J; Oosting J; Morreau H; van Wezel T
    Oncotarget; 2016 Mar; 7(12):14499-509. PubMed ID: 26894854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer.
    Michl M; Taverna F; Kumbrink J; Schiergens TS; Heinemann V; Engel J; Kirchner T; Neumann J
    Virchows Arch; 2021 Apr; 478(4):695-705. PubMed ID: 33300106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected.
    Sastre J; Orden V; Martínez A; Bando I; Balbín M; Bellosillo B; Palanca S; Peligros Gomez MI; Mediero B; Llovet P; Moral VM; Viéitez JM; García-Alfonso P; Calle SG; Ortiz-Morales MJ; Salud A; Quintero G; Lopez C; Díaz-Rubio E; Aranda E;
    Clin Colorectal Cancer; 2020 Sep; 19(3):e110-e116. PubMed ID: 32278676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of long-term outcomes between Lynch sydrome and sporadic colorectal cancer: a propensity score matching analysis.
    Xu Y; Li C; Zheng CZ; Zhang YQ; Guo TA; Liu FQ; Xu Y
    BMC Cancer; 2021 Jan; 21(1):45. PubMed ID: 33422027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific genomic aberrations in primary colorectal cancer are associated with liver metastases.
    Bruin SC; Klijn C; Liefers GJ; Braaf LM; Joosse SA; van Beers EH; Verwaal VJ; Morreau H; Wessels LF; van Velthuysen ML; Tollenaar RA; Van't Veer LJ
    BMC Cancer; 2010 Dec; 10():662. PubMed ID: 21126340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers.
    Orjuela S; Menigatti M; Schraml P; Kambakamba P; Robinson MD; Marra G
    BMC Cancer; 2020 Apr; 20(1):290. PubMed ID: 32252665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
    Gao B; Shao Q; Choudhry H; Marcus V; Dong K; Ragoussis J; Gao ZH
    Int J Oncol; 2016 Sep; 49(3):1108-18. PubMed ID: 27571956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and prognostic heterogeneity among RAS/BRAF
    Berg KCG; Brunsell TH; Sveen A; Alagaratnam S; Bjørnslett M; Hektoen M; Brudvik KW; Røsok BI; Bjørnbeth BA; Nesbakken A; Lothe RA
    Mol Oncol; 2021 Apr; 15(4):830-845. PubMed ID: 33325154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
    Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
    Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategies.
    Jesinghaus M; Pfarr N; Kloor M; Endris V; Tavernar L; Muckenhuber A; von Knebel Doeberitz M; Penzel R; Weichert W; Stenzinger A
    Genes Chromosomes Cancer; 2016 Mar; 55(3):268-77. PubMed ID: 26650777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-Seq profiling of circular RNAs in human colorectal Cancer liver metastasis and the potential biomarkers.
    Xu H; Wang C; Song H; Xu Y; Ji G
    Mol Cancer; 2019 Jan; 18(1):8. PubMed ID: 30630466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomics and proteomics approaches for biomarker discovery in sporadic colorectal cancer with metastasis.
    González-González M; Garcia JG; Montero JA; Fernandez LM; Bengoechea O; Muñez OB; Orfao A; Sayagues JM; Fuentes M
    Cancer Genomics Proteomics; 2013; 10(1):19-25. PubMed ID: 23382583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.